Petri Ylipaasto
- Genetics top 5%
- Diabetes and associated disorders 12
- Virus-based gene therapy research 4
- Infectious Diseases top 5%
- Viral gastroenteritis research and epidemiology 14
- Gastroenterology top 5%
-
- Viral Infections and Immunology Research 13
-
- Pancreatic function and diabetes 8
-
- Animal Virus Infections Studies 3
-
- Immune Response and Inflammation 2
-
- Endoplasmic Reticulum Stress and Disease 2
- Co-authors
- Merja RoivainenTimo OtonkoskiT HoviAnders LindbergTapani HoviReinhard KandolfKarin KlingelSuvi Rasilainen
- Journals
- The Journal of Clinical Endocrinology & Metabolism (1 paper)Annals of the New York Academy of Sciences (1 paper)Diabetologia (4 papers)
- Partner nations
- FinlandUnited StatesSweden
In The Last Decade
Petri Ylipaasto
24 papers receiving 891 citations
Peers
Comparison fields: 5 of 64
- Genetics 574
- Infectious Diseases 338
- Gastroenterology 81
- Cardiology and Cardiovascular Medicine 303
- Endocrinology, Diabetes and Metabolism 175
Countries citing papers authored by Petri Ylipaasto
This map shows the geographic impact of Petri Ylipaasto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petri Ylipaasto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petri Ylipaasto more than expected).
Fields of papers citing papers by Petri Ylipaasto
This network shows the impact of papers produced by Petri Ylipaasto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petri Ylipaasto. The network helps show where Petri Ylipaasto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Petri Ylipaasto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 10 | |
| 2 | 2012 | 4 | |
| 3 | Vitronectin receptors, alpha v integrins, are recognized by several non-RGD-containing echoviruses in a continuous laboratory cell line and also in primary human Langerhans' islets and endothelial cells | 2010 | 6 |
| 4 | 2010 | 69 | |
| 5 | 2009 | 16 | |
| 6 | 2008 | 14 | |
| 7 | 2008 | 26 | |
| 8 | 2008 | 21 | |
| 9 | 2008 | 27 | |
| 10 | 2005 | 99 | |
| 11 | 2005 | 3 | |
| 12 | 2005 | 17 | |
| 13 | 2004 | 13 | |
| 14 | 2004 | 14 | |
| 15 | 2004 | 211 | |
| 16 | 2004 | 11 | |
| 17 | 2003 | 44 | |
| 18 | 2003 | 12 | |
| 19 | 2002 | 83 | |
| 20 | 2000 | 127 |
About Petri Ylipaasto
Petri Ylipaasto is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Genetics, having authored 24 papers that have together received 903 indexed citations. Recurring topics across this work include Viral gastroenteritis research and epidemiology (14 papers), Viral Infections and Immunology Research (13 papers), Diabetes and associated disorders (12 papers), Pancreatic function and diabetes (8 papers), Virus-based gene therapy research (4 papers), Animal Virus Infections Studies (3 papers), Immune Response and Inflammation (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). The work is most often cited by research in Genetics (574 citations), Infectious Diseases (338 citations) and Gastroenterology (81 citations). Petri Ylipaasto has collaborated with scholars based in Finland, United States and Sweden. Frequent co-authors include Merja Roivainen, Timo Otonkoski, T Hovi, Anders Lindberg, Tapani Hovi, Reinhard Kandolf, Karin Klingel, Suvi Rasilainen, Décio L. Eizirik and Teemu Smura. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Annals of the New York Academy of Sciences and Diabetologia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.